218 related articles for article (PubMed ID: 12920220)
1. Grading of atypia in nevi: correlation with melanoma risk.
Arumi-Uria M; McNutt NS; Finnerty B
Mod Pathol; 2003 Aug; 16(8):764-71. PubMed ID: 12920220
[TBL] [Abstract][Full Text] [Related]
2. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
3. Grade of atypia in dysplastic nevi and relationship with dermal fibroplasia.
Babacan A; Lebe B
Turk Patoloji Derg; 2012; 28(1):17-23. PubMed ID: 22207427
[TBL] [Abstract][Full Text] [Related]
4. Critical analysis of histologic criteria for grading atypical (dysplastic) melanocytic nevi.
Pozo L; Naase M; Cerio R; Blanes A; Diaz-Cano SJ
Am J Clin Pathol; 2001 Feb; 115(2):194-204. PubMed ID: 11211607
[TBL] [Abstract][Full Text] [Related]
5. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology.
Rhodes AR; Mihm MC; Weinstock MA
Mod Pathol; 1989 Jul; 2(4):306-19. PubMed ID: 2762287
[TBL] [Abstract][Full Text] [Related]
6. Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi.
Touab M; Arumi-Uría M; Barranco C; Bassols A
Am J Clin Pathol; 2003 Apr; 119(4):587-93. PubMed ID: 12710131
[TBL] [Abstract][Full Text] [Related]
7. Severe architectural disorder is a potential pitfall in the diagnosis of small melanocytic lesions.
Torres-Cabala CA; Plaza JA; Diwan AH; Prieto VG
J Cutan Pathol; 2010 Aug; 37(8):860-5. PubMed ID: 19614731
[TBL] [Abstract][Full Text] [Related]
8. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
[TBL] [Abstract][Full Text] [Related]
9. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.
Shors AR; Kim S; White E; Argenyi Z; Barnhill RL; Duray P; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Rabkin MS; Schmidt B; Shea CR; Trotter MJ; Piepkorn MW
Br J Dermatol; 2006 Nov; 155(5):988-93. PubMed ID: 17034530
[TBL] [Abstract][Full Text] [Related]
10. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
11. Atypical genital nevi. A clinicopathologic analysis of 56 cases.
Gleason BC; Hirsch MS; Nucci MR; Schmidt BA; Zembowicz A; Mihm MC; McKee PH; Brenn T
Am J Surg Pathol; 2008 Jan; 32(1):51-7. PubMed ID: 18162770
[TBL] [Abstract][Full Text] [Related]
12. In vivo confocal microscopy for detection and grading of dysplastic nevi: a pilot study.
Pellacani G; Farnetani F; Gonzalez S; Longo C; Cesinaro AM; Casari A; Beretti F; Seidenari S; Gill M
J Am Acad Dermatol; 2012 Mar; 66(3):e109-21. PubMed ID: 21742408
[TBL] [Abstract][Full Text] [Related]
13. Melanoma risk in individuals with clinically atypical nevi.
Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
[TBL] [Abstract][Full Text] [Related]
14. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
Ko CJ; McNiff JM; Glusac EJ
J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
[TBL] [Abstract][Full Text] [Related]
15. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
Piepkorn M
Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
[TBL] [Abstract][Full Text] [Related]
16. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
17. [The number and distribution of nevus cell nevi in patients with malignant melanoma].
Welkovich B; Landthaler M; Schmoeckel C; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):630-5. PubMed ID: 2613517
[TBL] [Abstract][Full Text] [Related]
18. Melanocytic lesions of the genital area with attention given to atypical genital nevi.
Ribé A
J Cutan Pathol; 2008 Nov; 35 Suppl 2():24-7. PubMed ID: 18976416
[TBL] [Abstract][Full Text] [Related]
19. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
[TBL] [Abstract][Full Text] [Related]
20. Eruptive post-chemotherapy in situ melanomas and dysplastic nevi.
Reutter JC; Long EM; Morrell DS; Thomas NE; Groben PA
Pediatr Dermatol; 2007; 24(2):135-7. PubMed ID: 17461808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
